WuXi PharmaTech And Covance To Partner On Preclinical Testing In China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - WuXi PharmaTech, China's leading contract research organization, and Princeton, N.J.-based Covance are set to create a joint venture to provide preclinical drug testing services in China
You may also be interested in...
WuXi PharmaTech To Transfer Biologics Testing And Manufacturing From U.S. AppTec To New China Lab
BEIJING - While reporting surging earnings growth for the second quarter of 2008, WuXi PharmaTech said the company would begin transferring biologics testing and manufacturing from recently acquired American AppTec Laboratory Services to China
WuXi PharmaTech To Transfer Biologics Testing And Manufacturing From U.S. AppTec To New China Lab
BEIJING - While reporting surging earnings growth for the second quarter of 2008, WuXi PharmaTech said the company would begin transferring biologics testing and manufacturing from recently acquired American AppTec Laboratory Services to China
China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
Small companies struggle to advance in new, stricter regulatory environment.